Eupraxia Pharmaceuticals Inc.

EPRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$33,101$19,342$24,728$20,892
Short-Term Investments$0$0$0$9,009
Receivables$229$191$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,107$271$441$701
Total Curr. Assets$34,437$19,803$25,169$30,602
Property Plant & Equip (Net)$425$456$719$589
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$81$7$3$31
Total NC Assets$506$463$722$620
Other Assets$0$0$0$0
Total Assets$34,942$20,266$25,891$31,222
Liabilities
Payables$0$0$0$0
Short-Term Debt$72$10,452$176$155
Tax Payable$0$36$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,032$8,885$3,965$2,113
Total Curr. Liab.$3,103$19,374$4,141$2,268
LT Debt$0$0$11,991$9,836
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0-$0-$0
Total NC Liab.$0$0$11,991$9,836
Other Liabilities$0$0$0$0
Cap. Leases$72$53$138$198
Total Liabilities$3,103$19,374$16,131$12,104
Equity
Pref Stock$31,705$0$0$0
Common Stock$116,360$92,914$96,135$77,649
Retained Earnings-$131,004-$105,501-$104,633-$74,257
AOCI-$4,161-$2,707-$3,773$16,560
Other Equity$20,504$17,510$22,813$0
Total Equity$33,405$2,216$10,543$19,952
Supplemental Information
Minority Interest-$1,566-$1,324-$783-$834
Total Liab. & Tot. Equity$34,942$20,266$25,891$31,222
Net Debt-$33,029-$8,890-$12,561-$10,901
Eupraxia Pharmaceuticals Inc. (EPRX) Financial Statements & Key Stats | AlphaPilot